| Updated 2016 EAU guidelines on muscle-invasive and metastatic bladder cancer JA Witjes, T Lebret, EM Compérat, NC Cowan, M De Santis, HM Bruins, ... European urology 71 (3), 462-475, 2017 | 1762* | 2017 |
| European Association of Urology guidelines on muscle-invasive and metastatic bladder cancer: summary of the 2020 guidelines JA Witjes, HM Bruins, R Cathomas, EM Compérat, NC Cowan, G Gakis, ... European urology 79 (1), 82-104, 2021 | 1518 | 2021 |
| EAU guidelines on muscle-invasive and metastatic bladder cancer: summary of the 2013 guidelines JA Witjes, E Compérat, NC Cowan, M De Santis, G Gakis, T Lebret, ... European urology 65 (4), 778-792, 2014 | 1185 | 2014 |
| Results of a randomised controlled trial comparing intravesical chemohyperthermia with mitomycin C versus bacillus Calmette-Guérin for adjuvant treatment of patients with … TJH Arends, O Nativ, M Maffezzini, O de Cobelli, G Canepa, F Verweij, ... European urology 69 (6), 1046-1052, 2016 | 241 | 2016 |
| Preliminary European results of local microwave hyperthermia and chemotherapy treatment in intermediate or high risk superficial transitional cell carcinoma of the bladder AG Van der Heijden, LA Kiemeney, ON Gofrit, O Nativ, A Sidi, Z Leib, ... European urology 46 (1), 65-72, 2004 | 225 | 2004 |
| The impact of the extent of lymphadenectomy on oncologic outcomes in patients undergoing radical cystectomy for bladder cancer: a systematic review HM Bruins, E Veskimae, V Hernandez, M Imamura, MM Neuberger, ... European urology 66 (6), 1065-1077, 2014 | 209 | 2014 |
| European Association of Urology (EAU) prognostic factor risk groups for non–muscle-invasive bladder cancer (NMIBC) incorporating the WHO 2004/2016 and WHO 1973 classification … RJ Sylvester, O Rodríguez, V Hernández, D Turturica, L Bauerová, ... European urology 79 (4), 480-488, 2021 | 191 | 2021 |
| The 2021 updated European Association of Urology guidelines on metastatic urothelial carcinoma R Cathomas, A Lorch, HM Bruins, EM Compérat, NC Cowan, ... European urology 81 (1), 95-103, 2022 | 180 | 2022 |
| EAU-ESMO Consensus statements on the management of advanced and variant bladder cancer—an international collaborative multistakeholder effort†: under the auspices of the EAU … JA Witjes, M Babjuk, J Bellmunt, HM Bruins, TM De Reijke, M De Santis, ... European urology 77 (2), 223-250, 2020 | 166 | 2020 |
| Combined local bladder hyperthermia and intravesical chemotherapy for the treatment of high-grade superficial bladder cancer ON Gofrit, A Shapiro, D Pode, A Sidi, O Nativ, Z Leib, JA Witjes, ... Urology 63 (3), 466-471, 2004 | 158 | 2004 |
| Effect of hyperthermia on the cytotoxicity of 4 chemotherapeutic agents currently used for the treatment of transitional cell carcinoma of the bladder: an in vitro study AG van der HEIJDEN, G Verhaegh, CFJ Jansen, JA Schalken, JA Witjes The Journal of urology 173 (4), 1375-1380, 2005 | 140 | 2005 |
| Trained immunity as a molecular mechanism for BCG immunotherapy in bladder cancer JH van Puffelen, ST Keating, E Oosterwijk, AG van der Heijden, MG Netea, ... Nature Reviews Urology 17 (9), 513-525, 2020 | 119 | 2020 |
| Recurrent urinary tract infection and risk of bladder cancer in the Nijmegen bladder cancer study SH Vermeulen, N Hanum, AJ Grotenhuis, G Castano-Vinyals, ... British journal of cancer 112 (3), 594-600, 2015 | 106 | 2015 |
| Treatment of high-grade non–muscle-invasive bladder carcinoma by standard number and dose of BCG instillations versus reduced number and standard dose of BCG instillations … MO Grimm, AG van der Heijden, M Colombel, T Muilwijk, ... European urology 78 (5), 690-698, 2020 | 99 | 2020 |
| Phase II marker lesion study with intravesical instillation of apaziquone for superficial bladder cancer: toxicity and marker response AG van der Heijden, PMJ Moonen, EB Cornel, H Vergunst, TM de Reijke, ... The Journal of urology 176 (4), 1349-1353, 2006 | 97 | 2006 |
| Recurrence, progression, and follow-up in non–muscle-invasive bladder cancer AG van der Heijden, JA Witjes European Urology Supplements 8 (7), 556-562, 2009 | 90 | 2009 |
| Intravesical gemcitabine: a phase 1 and pharmacokinetic study JA Witjes, AG Van Der Heijden, JLJ Vriesema, GJ Peters, A Laan, ... European urology 45 (2), 182-186, 2004 | 90 | 2004 |
| Comparison of hexaminolevulinate based flexible and rigid fluorescence cystoscopy with rigid white light cystoscopy in bladder cancer: results of a prospective Phase II study JA Witjes, PMJ Moonen, AG van der Heijden European urology 47 (3), 319-322, 2005 | 89 | 2005 |
| Systematic review of the oncological and functional outcomes of pelvic organ‐preserving radical cystectomy (RC) compared with standard RC in women who undergo curative surgery … E Veskimäe, Y Neuzillet, M Rouanne, S MacLennan, TBL Lam, Y Yuan, ... BJU international 120 (1), 12-24, 2017 | 86 | 2017 |
| EAU–ESMO consensus statements on the management of advanced and variant bladder cancer—an international collaborative multi-stakeholder effort: under the auspices of the EAU … A Horwich, M Babjuk, J Bellmunt, HM Bruins, TM De Reijke, M De Santis, ... Annals of Oncology 30 (11), 1697-1727, 2019 | 82 | 2019 |
